Clinical Trials List
Protocol NumberMK-9999-01B
Completed
2024-08-01 - 2031-12-31
Phase I/II
Recruiting1
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 張修豪 Division of Pediatrics
- 周書緯 Division of Pediatrics
- YUNG-LI YANG Division of Others -
- Chia-Chi Lin Division of Hematology & Oncology
- MENG-YAO LU Division of Pediatrics
- 杜佳叡 Division of Others
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
1 participants
-
Global
60 participants
